MEDICA Newsletter
Social Media
More about…
- 3D printing and additive manufacturing
- Adiposity
- Age
- Alzheimer's
- Antibiotics
- Artificial intelligence
- Biocompatible
- Biomarker
- Biotechnology
- Blood
- Brain
- Brain Tumour
- Breast
- CT
- Cancer
- Cardiovascular diseases
- Care
- Cells
- Communication
- Dementia
- Depression
- Devices
- Diabetes
- Diagnostics
- Disinfection
- Drugs
- EEG
- EU
- Environment
- Epilepsy
- Eyes
- Financing
- Fitness
- Genetic material
- Genetics
- Germany
- Global health
- Gynecology
- Healthcare politics
- Heart
- Hospital
- Hospital information system
- Hygiene
- Imaging
- Immune system
- Implants
- Infectious diseases
- Information technology
- Intestine
- Kidney
- Knee
- Laboratory
- Laser
- Liver
- Lung
- MEDICA 2022
- MRI
- Mammography
- Materials
- Media
- Medical apps
- Medical market
- Microtechnology
- Minimally invasive
- Multiple Sclerosis
- Nanotechnology
- Neurology
- Nuclear medicine
- Nutrition
- Optical technologies
- Optimisation
- Organs
- Orthopedics
- Pain
- Pathogens
- Pathology
- Patients
- Personalized Medicine
- Physiotherapy
- Pregnancy
- Prevention
- Prosthesis
- Psychology
- Radiology
- Regenerative Medicine
- Rehabilitation
- Research
- Risks
- Robotics
- SARS-CoV-2/COVID-19
- Safety
- Screening
- Screening
- Senses
- Skin
- Sleep
- Smart textiles
- Software
- Sports medicine
- Stem cells
- Sterilisation
- Stroke
- Surgery
- Surgical intervention
- Telemedicine
- Therapy
- Tissue engineering
- Transplantation
- Treatment
- Ultrasound
- Vaccination
- Virtual Reality and Augmented Reality
- Wearable technologies
- Women
- Wound care and wound healing
- X-ray devices
- mHealth
sofiiashunkina
Complete package for minimally invasive tumor therapy
04/01/2023
License agreement and joint development: Fraunhofer MEVIS commences cooperation with Israeli partner for worldwide use of innovative software technology in ultrasound-aided tumor ablation.
Tel Aviv University
Ultrasound and nanobubbles allow cancerous tumors to be destroyed
23/11/2022
A new technology developed at Tel Aviv University makes it possible to destroy cancerous tumors in a targeted manner, via a combination of ultrasound and the injection of nanobubbles into the bloodstream.